Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer.
J Gastrointest Oncol. 2017 Feb;8(1):70-80. doi: 10.21037/jgo.2017.01.03.
J Gastrointest Oncol. 2017.
PMID: 28280611
Free PMC article.